Internal Medicine
M-A | Costs of multimorbidity.
20 Jul, 2022 | 12:06h | UTCCosts of multimorbidity: a systematic review and meta-analyses – BMC Medicine
Related:
Systematic review of high-cost patients’ characteristics and healthcare utilization – BMJ Open
Multimorbidity: a priority for global health research – The Academy of Medical Sciences
The global burden of multiple chronic conditions: A narrative review – Preventive Medicine Reports
Redesigning Care for High-Cost, High-Risk Patients – Harvard Business Review
Multimorbidity: clinical assessment and management – NICE Guideline
Richard Smith: The challenge of high need, high cost patients – The BMJ Blogs
Better Care for People with Complex Needs – Institute for Healthcare Improvement
Review | Contrast-associated acute kidney injury.
20 Jul, 2022 | 12:00h | UTCContrast-Associated Acute Kidney Injury – Journal of Clinical Medicine
Retrospective Cohort Study | The impact of frailty on short-term mortality following primary total hip and knee arthroplasty due to osteoarthritis.
20 Jul, 2022 | 11:50h | UTC
Systematic Review | Impact of early postoperative indwelling urinary catheter removal.
20 Jul, 2022 | 11:48h | UTC
Review | Opioid sparing strategies for perioperative pain management other than regional anesthesia.
20 Jul, 2022 | 11:47h | UTC
Review | New antibiotics for hospital-acquired pneumonia and ventilator-associated pneumonia.
20 Jul, 2022 | 11:44h | UTC
Addressing palliative care and end-of-life issues in patients with advanced cancer: a systematic review of communication interventions for physicians not specialized in palliative care.
20 Jul, 2022 | 11:40h | UTC
Podcast | Diagnosis, prevention, and treatment of Monkeypox.
19 Jul, 2022 | 13:44h | UTCDiagnosis, Prevention, and Treatment of Monkeypox – JAMA
EASL Clinical Practice Guidelines on the management of cystic liver diseases.
19 Jul, 2022 | 13:34h | UTCEASL Clinical Practice Guidelines on the management of cystic liver diseases – Journal of Hepatology
Commentary on Twitter
🆕 @EASLnews Clinical Practice Guidelines on the management of cystic liver diseases‼️
Direct link👉 https://t.co/qURCSBBRXD@EASLedu @joostphdrenth @torra_roser#LiverTwitter pic.twitter.com/mIIYZyvhQr
— Journal of Hepatology (@JHepatology) June 18, 2022
EASL Clinical Practice Guidelines on sclerosing cholangitis.
19 Jul, 2022 | 13:36h | UTCEASL Clinical Practice Guidelines on sclerosing cholangitis – Journal of Hepatology
Commentary on Twitter
🆕 @EASLnews Clinical Practice Guidelines on the management on sclerosing cholangitis, in press‼️
Direct link👉 https://t.co/FmtamRPaBX@EASLedu @tomhemmingk@DrCynthiaLevy #LiverTwitter pic.twitter.com/8oRiHt4jKV
— Journal of Hepatology (@JHepatology) June 21, 2022
Guidelines for the pharmacological management of rheumatoid arthritis with disease-modifying anti-rheumatic drugs.
19 Jul, 2022 | 13:30h | UTCRelated:
Rheumatoid arthritis in adults: management – National Institute for Health and Care Excellence
Review and Clinical Guidance | Respiratory events with Terlipressin and albumin in hepatorenal syndrome.
19 Jul, 2022 | 13:32h | UTC
Management of interstitial lung disease (ILD) in myositis syndromes: a practical guide for clinicians.
19 Jul, 2022 | 13:13h | UTC
Review | Cardiometabolic comorbidities in cancer survivors.
19 Jul, 2022 | 13:17h | UTCCardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
Cross Sectional Study | Variation in population attributable fraction of dementia associated with potentially modifiable risk factors by race and ethnicity in the US.
19 Jul, 2022 | 13:08h | UTCCommentaries:
12 Risk Factors Linked to Dementia Could Be Modified, Reduce US Cases by 400,000 – HCP Live
Hypertension, obesity, physical inactivity among highest risk factors for dementia – Healio
Commentary on Twitter
Number of people w/dementia is growing worldwide; this article identifies 12 modifiable risk factors accounting for~ 40% of people w/dementia. Hypertension most imp, followed by obesity and physical inactivity. https://t.co/mD5lrqZTyf @JAMANetworkOpen Kudos @PLutsey & team. pic.twitter.com/LG5LjFHqV6
— Harlan Krumholz (@hmkyale) July 7, 2022
In this cross-sectional study, a large fraction of dementia cases in the US were associated with potentially modifiable risk factors, especially for Black and Hispanic individuals. https://t.co/v6g2HPNLpR
— JAMA Network Open (@JAMANetworkOpen) July 6, 2022
RCT | Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis.
19 Jul, 2022 | 13:06h | UTCTreat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial – Annals of Rheumatic Diseases (link to abstract – $ for full-text)
Commentary: TNF inhibitor tapered T2T strategy feasible in PsA and axSpA – medwireNews
Commentary on Twitter
Treat-to-target (#T2T) tapering strategy is an effective and safe alternative to a T2T full dose continuation strategy in patients with #psoriatic #arthritis and axial #spondyloarthritis with stable low disease activity using TNF inhibitorshttps://t.co/YhurbawiTm pic.twitter.com/1jj4zuYkPf
— Annals of the Rheumatic Diseases (@eular_ARD) June 18, 2022
EASL Clinical Practice Guidelines on hemochromatosis.
18 Jul, 2022 | 11:47h | UTCEASL Clinical Practice Guidelines on haemochromatosis – Journal of Hepatology
EASL Clinical Practice Guidelines on the management of hepatic encephalopathy.
18 Jul, 2022 | 11:49h | UTC
Commentary on Twitter
🆕 @EASLnews Clinical Practice Guidelines on the management of hepatic encephalopathy, in press‼️
Direct link👉https://t.co/MvNiPdfQg3@EASLedu @RautouE @mromerogomez @MontagneseSara @DebbieShawcros1#LiverTwitter pic.twitter.com/ebmA7ULGsD
— Journal of Hepatology (@JHepatology) June 17, 2022
Doctors tend to have unrealistic expectations of the success of multi-step medical procedures.
18 Jul, 2022 | 11:42h | UTCOriginal Study: Analysis of Physicians’ Probability Estimates of a Medical Outcome Based on a Sequence of Events – JAMA Network Open
Commentary on Twitter (thread – click for more)
This just out: Physicians do not logically/correctly estimate the probability of outcomes resulting from sequences of events – a thread. #conjunctionfallacy #probability #medicaldecisionmaking #clinicalreasoning #innumeracy #numeracy https://t.co/zGULPrdVBa @JAMANetworkOpen
— The Phlegmfighter (@phlegmfighter) June 27, 2022
Population-level risks of alcohol consumption by amount, geography, age, sex, and year | A systematic analysis for the Global Burden of Disease Study 2020.
18 Jul, 2022 | 11:39h | UTCCommentaries:
Alcohol is never good for people under 40, global study finds – The Guardian
Global study finds surprising results for alcohol consumption – CNN
No alcohol safe to drink, global study confirms – BBC
Commentary on Twitter (thread – click for more)
New #GBDStudy suggests alcohol consumption carries significant health risks and no benefits for young people; some older adults may benefit from drinking a small amount.
Find out more: https://t.co/nn3V68KNIX @IHME_UW pic.twitter.com/i5wz2AR94w
— The Lancet (@TheLancet) July 14, 2022
Network M-A | Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults.
18 Jul, 2022 | 11:41h | UTC
Cohort Study | Reactogenicity of simultaneous COVID-19 mRNA booster and influenza vaccination.
18 Jul, 2022 | 11:34h | UTCCommentaries:
More (mostly mild) side effects when flu vaccine given with COVID booster – CIDRAP
Incidence, risk factors, natural history, and hypothesized mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
18 Jul, 2022 | 11:30h | UTCNews Release: New study updates evidence on rare heart condition after covid vaccination – BMJ Newsroom
Position Paper | Post-discharge and long-term follow-up after an acute coronary syndrome.
18 Jul, 2022 | 11:22h | UTC
Commentary on Twitter
Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper, by Sabouret et alhttps://t.co/yqPzc0q7ya@SABOURETCardio pic.twitter.com/vd1NTKKZ57
— Giuseppe Biondi-Zoccai (@gbiondizoccai) July 16, 2022
Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988).
18 Jul, 2022 | 11:09h | UTC